Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7554/eLife.22416 http://scihub22266oqcxt.onion/10.7554/eLife.22416 C5340530!5340530!28244869     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       eLife 2017 ; 6 (ä): ä Nephropedia Template TP {{tp|p=28244869|t=2017. YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-?B |pdf=|usr=}}{{28244869}} gab.com Text YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF- B JO: eLife http://www.kidney.de/pget.php?&tw=1&pmid=28244869 #FOAvip The ubiquitin ligase TRAF6 is a key regulator of canonical I?B kinase (IKK)/NF-?B signaling in response to interleukin-1 (IL-1) stimulation. Here, we identified the deubiquitinating enzyme YOD1 (OTUD2) as a novel interactor of TRAF6 in human cells. YOD1 binds to the C-terminal TRAF homology domain of TRAF6 that also serves as the interaction surface for the adaptor p62/Sequestosome-1, which is required for IL-1 signaling to NF-?B. We show that YOD1 competes with p62 for TRAF6 association and abolishes the sequestration of TRAF6 to cytosolic p62 aggregates by a non-catalytic mechanism. YOD1 associates with TRAF6 in unstimulated cells but is released upon IL-1? stimulation, thereby facilitating TRAF6 auto-ubiquitination as well as NEMO/IKK? substrate ubiquitination. Further, IL-1 triggered IKK/NF-?B signaling and induction of target genes is decreased by YOD1 overexpression and augmented after YOD1 depletion. Hence, our data define that YOD1 antagonizes TRAF6/p62-dependent IL-1 signaling to NF-?B.DOI:http://dx.doi.org/10.7554/eLife.22416.001 Twit Text FOAVip YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF- B ????eLife http://www.kidney.de/pget.php?&tw=1&pmid=28244869 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28244869 #FOAvip English Wikipedia <ref>{{Cite pmid|28244869}}</ref> YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-?B #MMPMID28244869 Schimmack G; Schorpp K; Kutzner K; Gehring T; Brenke JK; Hadian K; Krappmann D eLife 2017[]; 6 (ä): ä PMID28244869show ga The ubiquitin ligase TRAF6 is a key regulator of canonical I?B kinase (IKK)/NF-?B signaling in response to interleukin-1 (IL-1) stimulation. Here, we identified the deubiquitinating enzyme YOD1 (OTUD2) as a novel interactor of TRAF6 in human cells. YOD1 binds to the C-terminal TRAF homology domain of TRAF6 that also serves as the interaction surface for the adaptor p62/Sequestosome-1, which is required for IL-1 signaling to NF-?B. We show that YOD1 competes with p62 for TRAF6 association and abolishes the sequestration of TRAF6 to cytosolic p62 aggregates by a non-catalytic mechanism. YOD1 associates with TRAF6 in unstimulated cells but is released upon IL-1? stimulation, thereby facilitating TRAF6 auto-ubiquitination as well as NEMO/IKK? substrate ubiquitination. Further, IL-1 triggered IKK/NF-?B signaling and induction of target genes is decreased by YOD1 overexpression and augmented after YOD1 depletion. Hence, our data define that YOD1 antagonizes TRAF6/p62-dependent IL-1 signaling to NF-?B.DOI:http://dx.doi.org/10.7554/eLife.22416.001 äYOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-?B (epmc).pdf DeepDyve Pubget Overpricing